Drug evaluation: Tagatose in the treatment of type 2 diabetes and obesity

Current Opinion in Investigational Drugs

Volumn 7, Issue 10, 2006, Pages 924-935

  Moore, Mary Courtney ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ALPHA GLUCOSIDASE; ALPHA GLUCOSIDASE INHIBITOR; INSULIN; LACTOSE; NATURLOSE; PLACEBO; SUCRASE; SUCROSE; SULFONYLUREA; SWEETENING AGENT; TAGATOSE; TETRAHYDROLIPSTATIN;

ABDOMINAL DISTENSION; ANEMIA; ANTIOXIDANT ACTIVITY; AREA UNDER THE CURVE; BLOATING; BODY WEIGHT DISORDER; CELL PROTECTION; CLINICAL TRIAL; DIARRHEA; DRUG BLOOD LEVEL; DRUG DESIGN; DRUG FORMULATION; DRUG METABOLISM; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; EATING DISORDER; ENTEROPATHY; FEMALE INFERTILITY; FERTILITY; FETOTOXICITY; FLATULENCE; GASTROINTESTINAL SYMPTOM; GENOTOXICITY; HEMOPHILIA; HEPATOMEGALY; HUMAN; HYPERTENSION; LIVER HYPERTROPHY; LIVER TOXICITY; LOW BIRTH WEIGHT; META ANALYSIS; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATENT; PROTEIN SYNTHESIS INHIBITION; REVIEW; STOMACH DISEASE; STRUCTURE ACTIVITY RELATION; SYSTEMATIC REVIEW;

ANIMALS; ANTI-OBESITY AGENTS; CLINICAL TRIALS, PHASE I; CLINICAL TRIALS, PHASE II; DIABETES MELLITUS, TYPE 2; HEXOSES; HUMANS; HYPOGLYCEMIC AGENTS; OBESITY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33750294083     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. 353553 Biospherics gets patent on use of tagatose for anemia and hemophilia. Biospherics Inc PRESS RELEASE 2000 January 26
2. 407255 Spherix to get patent on use of tagatose as drug to improve fertility. Biospherics, Inc PRESS RELEASE 2001 April 26
3. 564588 Spherix announces first sale of Naturlose for pharmaceutical use. Spherix Inc PRESS RELEASE 2004 October 14
4. 607768 Health benefits of tagatose praised in recent studies. Spherix Inc PRESS RELEASE 2005 June 16
5. 638977 Spherix given FDA OK to begin phase III diabetes trial. Spherix Inc PRESS RELEASE 2005 December 06
6. 644381 Spherix chooses ENVIRON to assist with diabetes clinical trial. Spherix Inc PRESS RELEASE 2006 January 10
7. 669134 Spherix plans Australian phase III diabetes trial of Naturlose. Spherix Inc PRESS RELEASE 2006 May 23
8. 672483 The metabolic effects of dietary supplementation with D-tagatose in patients with type 2 diabetes. Donner TW DIABETES 2006 66 6 Suppl 1 461P
9. 674842 Tagatose, the new GRAS sweetener and health product. Levin GV J MED FOOD 2002 5 1 23-36
10. 674844 D-Tagatose, a novel hexose: Acute effects on carbohydrate tolerance in subjects with and without type 2 diabetes. Donner TW, Wilber JF, Ostrowski D DIABETES OBESITY METAB 1999 1 5 285-291
11. 674845 Characteristics and significance of D-tagatose-induced liver enlargement in rats: An interpretative review. Bar A REGUL TOXICOL PHARMACOL 1999 29 2 S83-S93
12. 674846 Effects of acute and repeated oral doses of D-tagatose on plasma uric acid in normal and diabetic humans. Saunders JP, Donner TW, Sadler JH, Levin GV, Makris NG REGUL TOXICOL PHARMACOL 1999 29 2 S57-S65
13. 14C]tagatose in the rat. Saunders JP, Zehner LR, Levin GV REGUL TOXICOL PHARMACOL 1999 29 2 S46-S56
14. 674848 Developmental toxicity study of D-tagatose in rats. Kruger CL, Whittaker MH, Frankos VH, Schroeder RE REGUL TOXICOL PHARMACOL 1999 29 2 S29-S35
15. 674853 Antioxidant and cytoprotective properties of D-tagatose in cultured murine hepatocytes. Paterna JC, Boess F, Staeubli A, Boelsterli UA TOXICOL APPL PHARMACOL 1998 148 1 117-125
16. 674854 D-tagatose is a bulk sweetener with zero energy determined in rats. Livesey G, Brown JC J NUTR 1996 126 6 1601-1609
17. 674855 Antidiabetic effect of D-tagatose in SHR/N-cp rats. Szepesi B, Levin G, Zehner L, Saunders J FASEB J 1996 10 3 A461
18. 674856 D-tagatose: A novel therapeutic adjunct for non-insulin-dependent diabetes. Donner T, Wilber J, Ostrowski D DIABETES 1996 45 Suppl 2 125A
19. 674931 90-Day oral toxicity study of D-tagatose in rats. Kruger CL, Whittaker MH, Frankos VH, Trimmer GW REGUL TOXICOL PHARMACOL 1999 29 2 Pt 2 S1-S10
20. 676414 Spherix highlights anti-diabetes drug progress. Spherix Inc PRESS RELEASE 2006 June 29
21. 679421 Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: Variations with increasing levels of HbA1c. Monnier L, Lapinski H, Colette C DIABETES CARE 2003 26 3 881-885
22. 679423 Postprandial glucose regulation: New data and new implications. Leiter LA, Ceriello A, Davidson JA, Hanefeld M, Monnier L, Owens DR, Tajima N, Tuomilehto J CLIN THER 2005 27 Suppl 2 S42-S56
23. 679424 Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR Br Med J 2000 321 7258 405-412
24. 679426 Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: Meta-analysis of seven long-term studies. Hanefeld M, Cagatay M, Petrowitsch T, Neuser D, Petzinna D, Rupp M EUR HEART J 2004 25 1 10-16
25. 679427 The natural course of β-cell function in nondiabetic and diabetic individuals: The insulin resistance atherosclerosis study. Festa A, Williams K, D'Agostino R Jr, Wagenknecht LE, Haffner SM DIABETES 2006 55 4 1114-1120
26. 679428 Increase in D-tagatose production rate by site-directed mutagenesis of L-arabinose isomerase from Geobacillus thermodenitrificans. Oh HJ, Kim HJ, Oh DK BIOTECHNOL LETT 2006 28 3 145-149
27. 679429 The substrate and anomeric specificity of fructokinase. Raushel FM, Cleland WW J BIOL CHEM 1973 248 23 8174-8177
28. 679438 Effect of D-tagatose on liver weight and glycogen content of rats. Bar A, Lina BA, de Groot DM, de Bie B, Appel MJ REGUL TOXICOL PHARMACOL 1999 292 Pt2 S11-S28
29. 679439 Lower fat deposition and energy utilization of growing rats fed diets containing sorbose. Furuse M, Tamura Y, Matsuda S, Shimizu T, Okumura J COMP BIOCHEM PHYSIOL A 1989 94 4 813-817
30. 679440 Enlargement glycogen store in rat liver and muscle by fructose-diet intake and exercise training. Murakami T, Shimomura Y, Fujitsuka N, Sokabe M, Okamura K, Sakamoto S J APPL PHYSIOL 1997 82 3 772-775
31. 679441 Metabolic responses of white rats to balanced and imbalanced protein fed with different carbohydrates in 15% and 5% fat diets. Gaertner EB, Carroll C J NUTR 1967 91 1 69-78
32. 679442 Stimulating effects of low-dose fructose on insulin-stimulated hepatic glycogen synthesis in humans. Petersen KF, Laurent D, Yu C, Cline GW, Shulman GI DIABETES 2001 50 6 1263-1268
33. 679443 Effects of dietary carbohydrates on glucose and lipid metabolism in golden Syrian hamsters. Kasim-Karakas SE, Vriend H, Almario R, Chow LC, Goodman MN J LAS CLIN MED 1996 128 2 208-213
34. 679444 Small-bowel absorption of D-tagatose and related effects on carbohydrate digestibility: An ileostomy study. Normen L, Laerke HN, Jensen BB, Langkilde AM, Andersson H AM J CLIN NUTR 2001 73 1 105-110
35. 679445 The acute effect of D-tagatose on food intake in human subjects. Buemann B, Toubro S, Raben A, Blundell J, Astrup A BR J NUTR 2000 84 227-231
36. 679447 Human tolerance to a single, high dose of D-tagatose. Buemann B, Toubro S, Raben A, Astrup A REGUL TOXICOL PHARMACOL 1999 29 2 Pt 2 S66-S70
37. 679448 D-Tagatose, a stereolsomer of D-fructose, increases hydrogen production in humans without affecting 24-hour energy expenditure or respiratory exchange ratio. Buemann B, Toubro S, Astrup A J NUTR 1998 128 9 1481-1486
38. 679449 Tagatose and milk allergy. Taylor SL, Lambrecht DM, Hefle SL ALLERGY 2005 60 3 412-413
39. 679450 In vitro fermentation pattern of D-tagatose is affected by adaptation of the microbiota from the gastrointestinal tract of pigs. Laerke, HN, Jensen BB, Hojsgaard S J NUTR 2000 130 7 1772-1779
40. 679451 D-Tagatose has low small intestinal digestibility but high large intestinal fermentability in pigs. Laerke HN, Jensen BB J NUTR 1999 129 5 1002-1009
41. 679452 Acute fructose administration decreases the glycemic response to an oral glucose tolerance test in normal adults. Moore MC, Cherrington AD, Mann SL, Davis SN J CLIN ENDOCRINOL METAB 2000 85 12 4515-4519
42. 679453 Acute fructose administration improves oral glucose tolerance in adults with type 2 diabetes. Moore MC, Davis SN, Mann SL, Cherrington AD DIABETES CARE 2001 24 11 1882-1887
43. 679454 Effect of oral D-tagatose on liver volume and hepatic glycogen accumulation in healthy male volunteers. Boesch C, Ith M, Jung B, Bruegger K, Erban S, Diamantis I, Kreis R, Bar A REGUL TOXICOL PHARMACOL 2001 33 2 257-267
44. 679456 Control of glucokinase translocation in rat hepatocytes by sorbitol and the cytosolic redox state. Agius L BIOCHEM J 1994 298 1 237-243
45. 679458 Inclusion of low amounts of fructose with an intraduodenal glucose load markedly reduces postprandial hyperglycemia and hyperinsulinemia in the conscious dog. Shiota M, Moore MC, Galassetti P, Monohan M, Neal DW, Shulman GI, Cherrington AD DIABETES 2002 51 2 469-478
46. 681995 Genotoxicity tests on D-tagatose. Kruger CL, Whittaker MH, Frankos VH REGUL TOXICOL PHARMACOL 1999 29 2 Pt 2 S36-S42
47. 681996 Dietary fructose: Implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. Havel PJ NUTR REV 2005 63 5 133-157
48. 682001 Hepatic adaptations to sucrose and fructose. Bizeau ME, Pagliassotti MJ METABOLISM 2005 54 9 1189-1201
49. 682002 D-Tagatose, a sterecisomer of D-fructose, increases blood uric acid concentration. Buemann B, Toubro S, Holst JJ, Rehfeld JF, Bibby BM, Astrup A METABOLISM 2000 49 8 969-976
50. 31P-magnetic resonance spectroscopy. Buemann B, Gesmar H, Astrup A, Quistorff B METABOLISM 2000 49 10 1335-1339
51. 683571 Spherix signs Anaclim to support diabetes clinical trial. Spherix Inc PRESS RELEASE 2006 August 10
52. 685683 A systematic review of the clinical effectiveness of orlistat used for the management of obesity. O'Meara S, Riemsma R, Shirran L, Mather L, ter Piet G OBES REV 2004 5 1 51-68
53. 685690 Liver adenine nucleatides: Fructose-induced depletion and its effect on protein synthesis. Maenpaa PH, Raivio KO, Kekomaki MP SCIENCE 1968 161 847 1253-1254